Novartis earned $2.08 billion (SFr2.36 billion) on $10.75 billion in sales in the third quarter of 2008, the pharmaceutical giant said on Monday.This content was published on October 20, 2008 - 10:11
The result, a 12 per cent increase over the same period last year, brings the Basel-based firm's net sales to $31.38 billion and net income to $6.66 billion for the first nine months of the year.
The Swiss drugmaker had benefited from positive currency translation and in particular, from a weak United States dollar.
The group's operating income advanced 24 per cent to $7.28 billion up to September, which the firm credited to an efficiency initiative focusing on innovation and expanding high-growth markets.
Novartis also said it would be cutting 550 jobs in the US, following in the steps of rivals Pfizer, GlaxoSmithKline and France's Sanofi-Aventis.
On Friday, the firm also said it had appointed Joerg Reinhardt as it's chief operating officer and that the head of its consumer health unit, Thomas Ebeling, was leaving the company.
This article was automatically imported from our old content management system. If you see any display errors, please let us know: firstname.lastname@example.org